A regio- and stereoselective 1,3-dipolar cycloaddition for the synthesis of novel spiro-pyrrolothiazolyloxindoles and their antitubercular evaluation

被引：172

作者：

Prasanna, Pitchaimani ^{[1
]}

Balamurugan, Kamaraj ^{[1
]}

Perumal, Subbu ^{[1
]}

Yogeeswari, Perumal ^{[2
]}

Sriram, Dharmarajan ^{[2
]}

机构：

[1] Madurai Kamaraj Univ, Sch Chem, Dept Organ Chem, Madurai 625021, Tamil Nadu, India

[2] Birla Inst Technol & Sci Pilani, Pharm Grp, Med Chem & Antimycobacterial Res Lab, Hyderabad 500078, Andhra Pradesh, India

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2010年 / 45卷 / 12期

关键词：

Antitubercular activity; Mycobacterium tuberculosis; Azomethine ylide; 1,3-Dipolar cycloaddition; 2-(Arylmethylene)-2,3-dihydro-1H-inden-1-ones; Spiro-pyrrolothiazolyloxindoles; STRUCTURE-BASED DESIGN; MAMMALIAN-CELL CYCLE; ANTIMYCOBACTERIAL EVALUATION; REGIOSELECTIVE SYNTHESIS; UNCARIA-TOMENTOSA; FACILE SYNTHESIS; TANDEM PROTOCOL; NITRILE OXIDES; OXINDOLE; DISCOVERY;

D O I：

10.1016/j.ejmech.2010.09.019

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The 1,3-dipolar cycloaddition of azomethine ylides derived from substituted isatins and 1,3-thiazolane-4-carboxylic acid to a series of 2-(arylmethylene)-2,3-dihydro-1H-inden-1-ones afforded twenty nine novel spiro-pyrrolothiazolyloxindoles regio- and stereoselectively in moderate yields. These compounds were screened for their in vitro activity against Mycobacterium tuberculosis H37Ry (MTB) using agar dilution method. Among 29 compounds screened, spiro[5.3']-5'-nitrooxindole-spiro-[6.3"1-2,3-dihydro-1H-inden-1"-one-7-(2,3-dichlorophenyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]thiazole, was found to be the most active compound with MIC of 2.8 mu M against MTB, being 1.67 and 2.70 times more active than ciprofloxacin and ethambutol respectively. (C) 2010 Elsevier Masson SAS. All rights reserved.

引用

页码：5653 / 5661

页数：9

共 56 条

[1]

AMALRAJ A, 2003, BIOORGAN MED CHEM, V11, P407

[2]

AZZOLINA O, 1975, GAZZ CHIM ITAL, V105, P971

[3] Oxindole alkaloids from Uncaria tomentosa induce apoptosis in proliferating, G0/G1-arrested and bcl-2-expressing acute lymphoblastic leukaemia cells [J].

Bacher, N ;

Tiefenthaler, M ;

Sturm, S ;

Stuppner, H ;

Ausserlechner, MJ ;

Kofler, R ;

Konwalinka, G .

BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (05) :615-622

[4] A facile domino protocol for the regioselective synthesis and discovery of novel 2-amino-5-arylthieno-[2,3-b]thiophenes as antimycobacterial agents [J].

Balamurugan, Kamaraj ;

Perumal, Subbu ;

Reddy, Aaramadaka Sunil Kumar ;

Yogeeswari, Perumal ;

Sriram, Dharmarajan .

TETRAHEDRON LETTERS, 2009, 50 (45) :6191-6195

[5]

BASCOP SI, 1994, HETEROCYCLES, V38, P725

[6] Spirotryprostatin B, a novel mammalian cell cycle inhibitor produced by Aspergillus fumigatus [J].

Cui, CB ;

Kakeya, H ;

Osada, H .

JOURNAL OF ANTIBIOTICS, 1996, 49 (08) :832-835

[7] Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase [J].

Cui, CB ;

Kakeya, H ;

Osada, H .

TETRAHEDRON, 1996, 52 (39) :12651-12666

[8] A facile four-component tandem protocol for the synthesis of novel 2,6-diaryl-2,3-dihydro-1H-pyridin-4-ones [J].

Devi, Natarajan Savitha ;

Perumal, Subbu .

TETRAHEDRON LETTERS, 2007, 48 (32) :5627-5629

[9] Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis? [J].

Di Perri, G ;

Bonora, S .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (03) :593-602

[10] Structure-based design of potent non-peptide MDM2 inhibitors [J].

Ding, K ;

Lu, Y ;

Nikolovska-Coleska, Z ;

Qiu, S ;

Ding, YS ;

Gao, W ;

Stuckey, J ;

Krajewski, K ;

Roller, PP ;

Tomita, Y ;

Parrish, DA ;

Deschamps, JR ;

Wang, SM .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (29) :10130-10131

← 1 2 3 4 5 6 →